We are live on ! Find out more
LNAI

Lunai Bioworks
LNAI

27 hedge funds and large institutions have $403K invested in Lunai Bioworks in 2026 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 4

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

23% more funds holding

Funds holding: 22 → 27 (+5)

0.66% less ownership

Funds ownership: 4.75% → 4.09% (-0.66%)

59% less capital invested

Capital invested by funds: $982K → $403K (-$578K)

Holders
27
Holders Change
+5
Holders Change %
+22.73%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
6
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
+$62.1K
2
NMC
Nine Masts Capital
Hong Kong
+$48.5K
3
VF
Virtu Financial
New York
+$46.6K
4
XT
XTX Topco
Cayman Islands
+$32.6K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$31.8K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$147K
2
Citadel Advisors
Citadel Advisors
Florida
-$18.2K
3
Jane Street
Jane Street
New York
-$10.5K
4
Simplex Trading
Simplex Trading
Illinois
-$6.09K
5
UBS Group
UBS Group
Switzerland
-$4.04K

LNAI Hedge Fund Activity: Q1 2026 in Review

27 of the 8,203 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q1 2026, worth a combined $403K — down 59% from $982K a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new LNAI positions and 4 closed out — a net gain of 6 holders — while 6 added to existing stakes and 3 trimmed.

The largest buyer was Citigroup, opening a new position worth an estimated $62.1K. The largest seller was Millennium Management, exiting entirely with an estimated $147K sold.

  • 27 institutional investors held Lunai Bioworks (LNAI) as of Q1 2026, up from 22 in Q4 2025.
  • Funds reported $403K of Lunai Bioworks stock for Q1 2026, down 59% quarter-over-quarter.
  • 10 funds opened new Lunai Bioworks positions in Q1 2026 and 4 closed out, a net change of +6 holders.
  • The largest Lunai Bioworks buyer in Q1 2026 was Citigroup, an estimated $62.1K added.
  • The largest Lunai Bioworks seller in Q1 2026 was Millennium Management, an estimated $147K sold.

Based on aggregated 13F filings for Q1 2026.